4 Results for "

p53-R175H mutant cells

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "p53-R175H mutant cells" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-122578
CAS No.: 922150-12-7
Purity:  99.93%
Target:  

MDM-2/p53

Research Areas:  

Cancer

P53R3 is a potent p53 reactivator and restores sequence-specific DNA binding of p53 hot spot mutants, including p53 R175H, p53 R248W and p53 R273H. P53R3 induces p53-dependent antiproliferative effects with much higher specificity than PRIMA-1. P53R3 enhances the recruitment of wild-type p53 and p53 M237I to several target gene promoters. P53R3 strongly enhances the mRNA, total protein and cell surface expression of the death receptor death receptor 5 (DR5). P53R3 is used for cancer research .
loading...
    loading...
Cat. No.: HY-126905
CAS No.: 79514-41-3
Synonyms: NSC328784
Research Areas:  

Cancer

ZMC3 (NSC328784) is a zinc chelator. ZMC3 shows Zinc metallochaperone properties. ZMC3 shows enhanced sensitivity in p53-R175H mutant cells. ZMC3 increases the cell ROS level .
loading...
    loading...
Cat. No.: HY-186151
CAS No.: 1372406-51-3
Target:  

MDM-2/p53 Apoptosis

Research Areas:  

Cancer

UCI-LC0019 is a mutant p53 reactivator. UCI-LC0019 binds to mutant p53, induces wild-type-like conformational change, restores sequence-specific DNA binding activity, activates p53-dependent transcription programs, and does not act via thiol reactivity or glutathione depletion. UCI-LC0019 inhibits proliferation and induces apoptosis in cancer cells harboring mutant p53, with no significant effect on p53 null or wild-type p53 tumors cells. UCI-LC0019 exhibits anti-tumor activity in xenograft mouse models carrying p53R175H mutant tumors. UCI-LC0019 can be used for the research of cancer, such as ovarian cancer .
loading...
    loading...
Cat. No.: HY-183622
CAS No.: 304896-41-1
Target:  

MDM-2/p53

Research Areas:  

Cancer

UCI-1014 is a mutant p53 (p53 R175H) corrector/reactivator. UCI-1014 restores the wild-type-like DNA-binding activity of p53 R175H, promotes the redistribution of the mutant protein to chromatin, and induces the expression of p53-dependent target genes. UCI-1014 inhibits the proliferation of p53 R175H-mutant cancer cells through an SLC7A11-independent mechanism. UCI-1014 can be used for research related to p53-mutant cancers .
loading...
    loading...